U.S. Psoriasis Treatment Awareness & Satisfaction Report: A Review of 2023 - Provides Valuable Insights Into Must-Have Patient-Reported Data Points
September 26, 2024 04:17 ET
|
Research and Markets
Dublin, Sept. 26, 2024 (GLOBE NEWSWIRE) -- The "Psoriasis in the United States: A Review of 2023 - Key Insights into Treatment Awareness & Satisfaction" report has been added to ...
Psoriasis Global Market Report 2024: Market to Surge to $39.17 Billion by 2028, Middle East Poised for Rapid Growth - Long-term Forecasts to 2033
January 26, 2024 03:17 ET
|
Research and Markets
Dublin, Jan. 26, 2024 (GLOBE NEWSWIRE) -- The "Psoriasis Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The psoriasis market is undergoing significant...
Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Outlook 2024-2028: Product Innovations and Strategic Partnerships Catalyzing Industry Growth
January 23, 2024 11:48 ET
|
Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Tumor Necrosis Factor Inhibitor Drugs Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The tumor necrosis...
Global Biosimilar Market Size to Reach USD 132.47 Billion in 2032 | Emergen Research
December 05, 2023 09:23 ET
|
Emergen Research
Vancouver, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Global Biosimilar Market Poised for Rapid Growth with 17.9% CAGR, Fueled by Rising Cancer Cases and Regulatory Approvals In 2032, the global biosimilar...
Adalimumab, Infliximab And Etanercept Biosimilars Global Market Report 2023: Increasing Healthcare Access Bolsters Sector
January 11, 2023 04:48 ET
|
Research and Markets
Dublin, Jan. 11, 2023 (GLOBE NEWSWIRE) -- The "Adalimumab, Infliximab And Etanercept Biosimilars Global Market Opportunities And Strategies To 2031" report has been added to ...
China Infliximab Market Investigation Report 2022: Sales 2017-2021, Major Manufacturers 2017-2021, Prices for Different Manufacturers 2021-2022 and Prospects 2022-2031
August 10, 2022 05:28 ET
|
Research and Markets
Dublin, Aug. 10, 2022 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Infliximab Market 2022-2031" report has been added to ResearchAndMarkets.com's offering. According to this market...
Global TNF Alpha Inhibitors Market Report 2022-2026 & 2031 Featuring Major Players - AbbVie, Amgen, J&J, UCB, Novartis, Pfizer, Merck & Co, Janssen Biotech, Ablynx, and Momenta Pharmaceuticals
August 04, 2022 07:04 ET
|
Research and Markets
Dublin, Aug. 04, 2022 (GLOBE NEWSWIRE) -- The "TNF Alpha Inhibitors Global Market Report 2022: By Drug, By Route, By Disease" report has been added to ResearchAndMarkets.com's offering. The global...
China's Infliximab Markets, 2016-2020 & 2021-2025 - Relevant Concepts, Sales, Major Manufacturers, Prices, Prospects
July 29, 2021 08:33 ET
|
Research and Markets
Dublin, July 29, 2021 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Infliximab Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. Infliximab is a human-mouse...
Sorrento Announces Its Partner Mabpharm Has Received Marketing Approval In China For Infliximab Biobetter
July 20, 2021 09:00 ET
|
Sorrento Therapeutics, Inc.
China National Medical Product Administration (NMPA) has granted Mabpharm approval to market INFLIXIMAB biobetter in China.Sorrento holds commercialization rights outside of China and intends to meet...
Global TNF Alpha Inhibitors Market Report 2020: Market is Expected to Recover and Reach $42.86 Billion in 2023 - Long-term Forecast to 2025 & 2030
March 29, 2021 04:53 ET
|
Research and Markets
Dublin, March 29, 2021 (GLOBE NEWSWIRE) -- The "TNF Alpha Inhibitors Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering. The global...